Acorda Therapeutics Stock (NASDAQ:ACOR)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.87

52W Range

$0.61 - $24.20

50D Avg

$12.10

200D Avg

$13.17

Market Cap

$821.03K

Avg Vol (3M)

$125.68K

Beta

1.46

Div Yield

-

ACOR Company Profile


Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

102

IPO Date

Feb 10, 2006

Website

ACOR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Product$102.42M$103.84M$114.19M
Royalty$15.11M$14.88M-
Ampyra$63.94M$84.56M-
License Revenue$99.00K--
License-$500.00K-
Inbrija--$29.63M

Fiscal year ends in Dec 23 | Currency in USD

ACOR Financial Summary


Dec 23Dec 22Dec 21
Revenue$102.42M$118.57M$129.07M
Operating Income$-280.16M$-42.04M$-77.30M
Net Income$-252.85M$-65.92M$-103.95M
EBITDA$-280.16M$-10.03M$-44.80M
Basic EPS$-203.59$-66.90$-195.75
Diluted EPS$-203.59$-66.90$-195.75

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 23Nov 13, 23 | 5:43 PM
Q2 23Aug 08, 23 | 10:24 PM
Q1 23May 11, 23 | 8:22 PM

Peer Comparison


TickerCompany
SNOASonoma Pharmaceuticals, Inc.
AKANAkanda Corp.
BFRIBiofrontera Inc.
EVOKEvoke Pharma, Inc.
LFCRLifecore Biomedical, Inc.
UPCUniverse Pharmaceuticals INC
SHPHShuttle Pharmaceuticals Holdings, Inc.
DERMJourney Medical Corporation
PTPIPetros Pharmaceuticals, Inc.
CPIXCumberland Pharmaceuticals Inc.
JUPWSafety Shot Inc
LSDILucy Scientific Discovery Inc.
PRFXPainReform Ltd.
AGRXAgile Therapeutics, Inc.
PCRXPacira BioSciences, Inc.